Oxytocin receptor DNA methylation in postpartum depression

Psychoneuroendocrinology

Volumn 69, Issue , 2016, Pages 150-160

  Kimmel, Mary ^a,e   Clive, Makena ^a   Gispen, Fiona ^a   Guintivano, Jerry ^a   Brown, Tori ^a   Cox, Olivia ^a   Beckmann, Matthias W ^d   Kornhuber, Johannes ^d   Fasching, Peter A ^d   Osborne, Lauren M ^a   Binder, Elisabeth ^c   Payne, Jennifer L ^a   Kaminsky, Zachary ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^d UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Allopregnanolone; DNA methylation; Estradiol; OXTR; Postpartum depression; Trauma

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; ESTRADIOL; ESTROGEN RECEPTOR; OXYTOCIN RECEPTOR; PROGESTERONE; ELTANOLONE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; ESTRADIOL BLOOD LEVEL; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HORMONE DETERMINATION; HUMAN; INTRON; MICROARRAY ANALYSIS; OXTR GENE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUERPERAL DEPRESSION; PYROSEQUENCING; ANXIETY; ANXIETY DISORDER; BLOOD; GENETIC EPIGENESIS; GENETICS; METABOLISM; POSTNATAL DEPRESSION;

ADULT; ANXIETY; ANXIETY DISORDERS; CPG ISLANDS; DEPRESSION, POSTPARTUM; DNA METHYLATION; EPIGENESIS, GENETIC; ESTRADIOL; FEMALE; HUMANS; PREGNANOLONE; PROGESTERONE; PROSPECTIVE STUDIES; RECEPTORS, OXYTOCIN;

EID: 84963861035     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2016.04.008     Document Type: Article

References (66)

1. Ammerman R.T., Putnam F.W., Chard K.M., Stevens J., Van Ginkel J.B. PTSD in depressed mothers in home visitation. Psychol. Trauma: Theory Res. Pract. Policy 2012, 4.
2. Andreen L., Nyberg S., Turkmen S., van Wingen G., Fernandez G., Backstrom T. Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators. Psychoneuroendocrinology 2009, 34:1121-1132.
3. Aswathi A., Rajendiren S., Nimesh A., Philip R.R., Kattimani S., Jayalakshmi D., Ananthanarayanan P.H., Dhiman P. High serum testosterone levels during postpartum period are associated with postpartum depression. Asian J. Psychiatry 2015, 17:85-88.
4. Backstrom T., Haage D., Lofgren M., Johansson I.M., Stromberg J., Nyberg S., Andreen L., Ossewaarde L., van Wingen G.A., Turkmen S., Bengtsson S.K. Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons. Neuroscience 2011, 191:46-54.
5. Bakermans-Kranenburg M.J., van Ijzendoorn M.H., Riem M.M., Tops M., Alink L.R. Oxytocin decreases handgrip force in reaction to infant crying in females without harsh parenting experiences. Soc. Cogn. Affective Neurosci. 2012, 7:951-957.
6. Bali A., Jaggi A.S. Multifunctional aspects of allopregnanolone in stress and related disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 2014, 48:64-78.
7. Bartella V., Rizza P., Barone I., Zito D., Giordano F., Giordano C., Catalano S., Mauro L., Sisci D., Panno M.L., Fuqua S.A., Ando S. Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter. Breast Cancer Res. Treat. 2012, 134:569-581.
8. Bell A.F., Carter C.S., Steer C.D., Golding J., Davis J.M., Steffen A.D., Rubin L.H., Lillard T.S., Gregory S.P., Harris J.C., Connelly J.J. Interaction between oxytocin receptor DNA methylation and genotype is associated with risk of postpartum depression in women without depression in pregnancy. Front. Genet. 2015, 6:243.
9. Berretti R., Santoru F., Locci A., Sogliano C., Calza A., Choleris E., Porcu P., Concas A. Neonatal exposure to estradiol decreases hypothalamic allopregnanolone concentrations and alters agonistic and sexual but not affective behavior in adult female rats. Horm. Behav. 2014, 65:142-153.
10. Bloch M., Schmidt P.J., Danaceau M., Murphy J., Nieman L., Rubinow D.R. Effects of gonadal steroids in women with a history of postpartum depression. Am. J. Psychiatry 2000, 157:924-930.
11. Breese McCoy S.J. Postpartum depression: an essential overview for the practitioner. South. Med. J. 2011, 104:128-132.
12. Brunton P.J., Russell J.A., Hirst J.J. Allopregnanolone in the brain: protecting pregnancy and birth outcomes. Prog. Neurobiol. 2014, 113:106-136.
13. Bunevicius R., Kusminskas L., Mickuviene N., Bunevicius A., Pedersen C.A., Pop V.J. Depressive disorder and thyroid axis functioning during pregnancy. World J. Biol. Psychiatry 2009, 10:324-329.
14. Colantuoni C., Lipska B.K., Ye T., Hyde T.M., Tao R., Leek J.T., Colantuoni E.A., Elkahloun A.G., Herman M.M., Weinberger D.R., Kleinman J.E. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 2011, 478:519-523.
15. Cuijpers P., Brannmark J.G., van Straten A. Psychological treatment of postpartum depression: a meta-analysis. J. Clin. Psychol. 2008, 64:103-118.
16. Deligiannidis K.M., Sikoglu E.M., Shaffer S.A., Frederick B., Svenson A.E., Kopoyan A., Kosma C.A., Rothschild A.J., Moore C.M. GABAergic neuroactive steroids and resting-state functional connectivity in postpartum depression: a preliminary study. J. Psychiatr. Res. 2013, 47:816-828.
17. Devost D., Wrzal P., Zingg H.H. Oxytocin receptor signalling. Prog. Brain Res. 2008, 170:167-176.
18. Field T. Prenatal depression effects on early development: a review. Infant Behav. Dev. 2011, 34:1-14.
19. Fleming J.G., Spencer T.E., Safe S.H., Bazer F.W. Estrogen regulates transcription of the ovine oxytocin receptor gene through GC-rich SP1 promoter elements. Endocrinology 2006, 147:899-911.
20. Franczak A., Staszkiewicz J., Koziorowski M., Kotwica G. The influence of estradiol and progesterone on the concentrations of uterine oxytocin receptors and plasma PGFM in response to oxytocin in ovariectomized gilts. Reprod. Nutr. Dev. 2002, 42:327-338.
21. Gagnidze K., Weil Z.M., Faustino L.C., Schaafsma S.M., Pfaff D.W. Early histone modifications in the ventromedial hypothalamus and preoptic area following oestradiol administration. J. Neuroendocrinol. 2013, 25:939-955.
22. Girdler S.S., Lindgren M., Porcu P., Rubinow D.R., Johnson J.L., Morrow A.L. A history of depression in women is associated with an altered GABAergic neuroactive steroid profile. Psychoneuroendocrinology 2012, 37:543-553.
23. Guintivano J., Arad M., Gould T.D., Payne J.L., Kaminsky Z.A. Antenatal prediction of postpartum depression with blood DNA methylation biomarkers. Mol. Psychiatry 2014, 19:560-567.
24. Harony-Nicolas H., Mamrut S., Brodsky L., Shahar-Gold H., Barki-Harrington L., Wagner S. Brain region-specific methylation in the promoter of the murine oxytocin receptor gene is involved in its expression regulation. Psychoneuroendocrinology 2014, 39:121-131.
25. Hellgren C., Akerud H., Skalkidou A., Backstrom T., Sundstrom-Poromaa I. Low serum allopregnanolone is associated with symptoms of depression in late pregnancy. Neuropsychobiology 2014, 69:147-153.
26. Hirst K.P., Moutier C.Y. Postpartum major depression. Am. Fam. Physician 2010, 82:926-933.
27. Huber W., von Heydebreck A., Sultmann H., Poustka A., Vingron M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 2002, 18(Suppl. 1):S96-104.
28. Huffmeijer R., Tops M., Alink L.R., Bakermans-Kranenburg M.J., van Ijzendoorn M.H. Love withdrawal is related to heightened processing of faces with emotional expressions and incongruent emotional feedback: evidence from ERPs. Biol. Psychol. 2011, 86:307-313.
29. Jeong H.G., Lim J.S., Lee M.S., Kim S.H., Jung I.K., Joe S.H. The association of psychosocial factors and obstetric history with depression in pregnant women: focus on the role of emotional support. Gen. Hosp. Psychiatry 2013, 35:354-358.
30. Josefsson A., Berg G., Nordin C., Sydsjo G. Prevalence of depressive symptoms in late pregnancy and postpartum. Acta Obstet. Gynecol. Scand. 2001, 80:251-255.
31. Juif P.E., Breton J.D., Rajalu M., Charlet A., Goumon Y., Poisbeau P. Long-lasting spinal oxytocin analgesia is ensured by the stimulation of allopregnanolone synthesis which potentiates GABA(A) receptor-mediated synaptic inhibition. J. Neurosci. 2013, 33:16617-16626.
32. Knobloch H.S., Charlet A., Hoffmann L.C., Eliava M., Khrulev S., Cetin A.H., Osten P., Schwarz M.K., Seeburg P.H., Stoop R., Grinevich V. Evoked axonal oxytocin release in the central amygdala attenuates fear response. Neuron 2012, 73:553-566.
33. Lightman S.L., George C.L. Steroid hormones in 2013: Glucocorticoids: timing, binding and environment. Nat. Rev. Endocrinol. 2014, 10:71-72.
34. Magiakou M.A., Mastorakos G., Rabin D., Dubbert B., Gold P.W., Chrousos G.P. Hypothalamic corticotropin-releasing hormone suppression during the postpartum period: implications for the increase in psychiatric manifestations at this time. J. Clin. Endocrinol. Metab. 1996, 81:1912-1917.
35. Mamrut S., Harony H., Sood R., Shahar-Gold H., Gainer H., Shi Y.J., Barki-Harrington L., Wagner S. DNA methylation of specific CpG sites in the promoter region regulates the transcription of the mouse oxytocin receptor. PLoS One 2013, 8:e56869.
36. Mehta D., Quast C., Fasching P.A., Seifert A., Voigt F., Beckmann M.W., Faschingbauer F., Burger P., Ekici A.B., Kornhuber J., Binder E.B., Goecke T.W. The 5-HTTLPR polymorphism modulates the influence on environmental stressors on peripartum depression symptoms. J. Affect. Disord. 2012, 136:1192-1197.
37. Mehta D., Newport D.J., Frishman G., Kraus L., Rex-Haffner M., Ritchie J.C., Lori A., Knight B.T., Stagnaro E., Ruepp A., Stowe Z.N., Binder E.B. Early predictive biomarkers for postpartum depression point to a role for estrogen receptor signaling. Psychol. Med. 2014, 1-14.
38. Meltzer-Brody S., Bledsoe-Mansori S.E., Johnson N., Killian C., Hamer R.M., Jackson C., Wessel J., Thorp J. A prospective study of perinatal depression and trauma history in pregnant minority adolescents. Am. J. Obstet. Gynecol. 2013, 208(21):e211-217.
39. Miller L.J. Postpartum depression. JAMA 2002, 287:762-765.
40. Miranda T.B., Voss T.C., Sung M.H., Baek S., John S., Hawkins M., Grontved L., Schiltz R.L., Hager G.L. Reprogramming the chromatin landscape: interplay of the estrogen and glucocorticoid receptors at the genomic level. Cancer Res. 2013, 73:5130-5139.
41. Myers A.J., Williams L., Gatt J.M., McAuley-Clark E.Z., Dobson-Stone C., Schofield P.R., Nemeroff C.B. Variation in the oxytocin receptor gene is associated with increased risk for anxiety, stress and depression in individuals with a history of exposure to early life stress. J. Psychiatr. Res. 2014, 59:93-100.
42. O'Hara M.W. Postpartum depression: what we know. J. Clin. Psychol. 2009, 65:1258-1269.
43. Osborne L., Clive M., Kimmel M., Gispen F., Guintivano J., Brown T., Cox O., Judy J., Meilman S., Brier A., Beckmann M.W., Kornhuber J., Fasching P.A., Goes F., Payne J.L., Binder E.B., Kaminsky Z. Replication of epigenetic postpartum depression biomarkers and variation with hormone levels. Neuropsychopharmacology 2015, 41(6):1648-1658.
44. Pearlstein T., Howard M., Salisbury A., Zlotnick C. Postpartum depression. Am. J. Obstet. Gynecol. 2009, 200:357-364.
45. Pedersen C.A., Johnson J.L., Silva S., Bunevicius R., Meltzer-Brody S., Hamer R.M., Leserman J. Antenatal thyroid correlates of postpartum depression. Psychoneuroendocrinology 2007, 32:235-245.
46. Perroud N., Paoloni-Giacobino A., Prada P., Olie E., Salzmann A., Nicastro R., Guillaume S., Mouthon D., Stouder C., Dieben K., Huguelet P., Courtet P., Malafosse A. Increased methylation of glucocorticoid receptor gene (NR3C1) in adults with a history of childhood maltreatment: a link with the severity and type of trauma. Transl. Psychiatry 2011, 1:e59.
47. Provencal N., Binder E.B. The effects of early life stress on the epigenome: from the womb to adulthood and even before. Exp. Neurol. 2015, 268:10-20.
48. Quinones-Jenab V., Jenab S., Ogawa S., Adan R.A., Burbach J.P., Pfaff D.W. Effects of estrogen on oxytocin receptor messenger ribonucleic acid expression in the uterus, pituitary, and forebrain of the female rat. Neuroendocrinology 1997, 65:9-17.
49. Reiner I., Van I.M.H., Bakermans-Kranenburg M.J., Bleich S., Beutel M., Frieling H. Methylation of the oxytocin receptor gene in clinically depressed patients compared to controls: the role of OXTR rs53576 genotype. J. Psychiatr. Res. 2015, 65:9-15.
50. Robertson E., Grace S., Wallington T., Stewart D.E. Antenatal risk factors for postpartum depression: a synthesis of recent literature. Gen. Hosp. Psychiatry 2004, 26:289-295.
51. Schiller C.E., Schmidt P.J., Rubinow D.R. Allopregnanolone as a mediator of affective switching in reproductive mood disorders. Psychopharmacology (Berl.) 2014, 231:3557-3567.
52. Skrundz M., Bolten M., Nast I., Hellhammer D.H., Meinlschmidt G. Plasma oxytocin concentration during pregnancy is associated with development of postpartum depression. Neuropsychopharmacology 2011, 36:1886-1893.
53. Smith A.S., Tabbaa M., Lei K., Eastham P., Butler M.J., Linton L., Altshuler R., Liu Y., Wang Z. Local oxytocin tempers anxiety by activating GABA receptors in the hypothalamic paraventricular nucleus. Psychoneuroendocrinology 2015, 63:50-58.
54. Soufia M., Aoun J., Gorsane M.A., Krebs M.O. SSRIs and pregnancy: a review of the literature. Encephale 2010, 36:513-516.
55. Studd J.W. A guide to the treatment of depression in women by estrogens. Climacteric 2011.
56. Stuebe A.M., Grewen K., Pedersen C.A., Propper C., Meltzer-Brody S. Failed lactation and perinatal depression: common problems with shared neuroendocrine mechanisms?. J. Womens Health (Larchmt) 2012, 21:264-272.
57. Sundaram S., Harman J.S., Cook R.L. Maternal morbidities and postpartum depression: an analysis using the 2007 and 2008 Pregnancy Risk Assessment Monitoring System. Women Health Issues 2014, 24:e381-388.
58. Thompson R.J., Parker K.J., Hallmayer J.F., Waugh C.E., Gotlib I.H. Oxytocin receptor gene polymorphism (rs2254298) interacts with familial risk for psychopathology to predict symptoms of depression and anxiety in adolescent girls. Psychoneuroendocrinology 2011, 36:144-147.
59. Unternaehrer E., Meyer A.H., Burkhardt S.C., Dempster E., Staehli S., Theill N., Lieb R., Meinlschmidt G. Childhood maternal care is associated with DNA methylation of the genes for brain-derived neurotrophic factor (BDNF) and oxytocin receptor (OXTR) in peripheral blood cells in adult men and women. Stress 2015, 1-11.
60. Viguera A.C., Tondo L., Koukopoulos A.E., Reginaldi D., Lepri B., Baldessarini R.J. Episodes of mood disorders in 2,252 pregnancies and postpartum periods. Am. J. Psychiatry 2011, 168:1179-1185.
61. Vivar O.I., Zhao X., Saunier E.F., Griffin C., Mayba O.S., Tagliaferri M., Cohen I., Speed T.P., Leitman D.C. Estrogen receptor beta binds to and regulates three distinct classes of target genes. J. Biol. Chem. 2010, 285:22059-22066.
62. Windle R.J., Gamble L.E., Kershaw Y.M., Wood S.A., Lightman S.L., Ingram C.D. Gonadal steroid modulation of stress-induced hypothalamo-pituitary-adrenal activity and anxiety behavior: role of central oxytocin. Endocrinology 2006, 147:2423-2431.
63. Wrzal P.K., Devost D., Petrin D., Goupil E., Iorio-Morin C., Laporte S.A., Zingg H.H., Hebert T.E. Allosteric interactions between the oxytocin receptor and the beta2-adrenergic receptor in the modulation of ERK1/2 activation are mediated by heterodimerization. Cell. Signal. 2012, 24:342-350.
64. Wrzal P.K., Goupil E., Laporte S.A., Hebert T.E., Zingg H.H. Functional interactions between the oxytocin receptor and the beta2-adrenergic receptor: implications for ERK1/2 activation in human myometrial cells. Cell. Signal. 2012, 24:333-341.
65. Yim I.S., Glynn L.M., Schetter C.D., Hobel C.J., Chicz-Demet A., Sandman C.A. Prenatal beta-endorphin as an early predictor of postpartum depressive symptoms in euthymic women. J. Affect. Disord. 2010, 125:128-133.
66. Yim I.S., Tanner Stapleton L.R., Guardino C.M., Hahn-Holbrook J., Dunkel Schetter C. Biological and psychosocial predictors of postpartum depression: systematic review and call for integration. Annu. Rev. Clin. Psychol. 2015, 11:99-137.